相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The histone deacetylase inhibitor panobinostat lowers biomarkers of cardiovascular risk and inflammation in HIV patients
Anne Sofie Hogh Kolbaek Kjaer et al.
AIDS (2015)
Understanding HIV Latency: The Road to an HIV Cure
Matthew S. Dahabieh et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Self-Immolative Linkers Literally Bridge Disulfide Chemistry and the Realm of Thiol-Free Drugs
Camilla Frich Riber et al.
ADVANCED HEALTHCARE MATERIALS (2015)
Highly Active Macromolecular Prodrugs Inhibit Expression of the Hepatitis C Virus Genome in the Host Cells
Pau Ruiz-Sanchis et al.
ADVANCED HEALTHCARE MATERIALS (2015)
Disulfide reshuffling triggers the release of a thiol-free anti-HIV agent to make up fast-acting, potent macromolecular prodrugs
Anders Kock et al.
CHEMICAL COMMUNICATIONS (2014)
Polymer therapeutics: Top 10 selling pharmaceuticals - What next?
Ruth Duncan
JOURNAL OF CONTROLLED RELEASE (2014)
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
Thomas A. Rasmussen et al.
LANCET HIV (2014)
Antibody-Drug Conjugates in Cancer Therapy
Eric L. Sievers et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Narrow Therapeutic Window of Ribavirin as an Inhibitor of Nitric Oxide Synthesis is Broadened by Macromolecular Prodrugs
Benjamin M. Wohl et al.
BIOMACROMOLECULES (2013)
An Integrated Overview of HIV-1 Latency
Debbie S. Ruelas et al.
CELL (2013)
Tenofovir, Emtricitabine Intracellular and Plasma, and Efavirenz Plasma Concentration Decay Following Drug Intake Cessation: Implications for HIV Treatment and Prevention
Akil Jackson et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Maturing antibody-drug conjugate pipeline hits 30
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2013)
Comparison of HDAC inhibitors in clinical development Effect on HIV production in latently infected cells and T-cell activation
Thomas Aagaard Rasmussen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Living Radical Polymerization by the RAFT Process - A Third Update
Graeme Moad et al.
AUSTRALIAN JOURNAL OF CHEMISTRY (2012)
Antiretroviral dynamics determines HIV evolution and predicts therapy outcome
Daniel I. S. Rosenbloom et al.
NATURE MEDICINE (2012)
Self-immolative linkers in polymeric delivery systems
Christopher A. Blencowe et al.
POLYMER CHEMISTRY (2011)
HPMA copolymers: Origins, early developments, present, and future
Jindrich Kopecek et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Synthesis of Functional Polymers by Post-Polymerization Modification
Marc A. Gauthier et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Prodrug strategies in anticancer chemotherapy
Felix Kratz et al.
CHEMMEDCHEM (2008)
Optimization and scale-up of the grandberg synthesis of 2-methyltryptamine
Joel Slade et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2007)
Polymer conjugates as anticancer nanomedicines
Ruth Duncan
NATURE REVIEWS CANCER (2006)
The dawning era of polymer therapeutics
R Duncan
NATURE REVIEWS DRUG DISCOVERY (2003)
HIV reproducibly establishes a latent infection after acute infection of T cells in vitro
A Jordan et al.
EMBO JOURNAL (2003)
Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities
G Saito et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)